7.2.1-header-iStock-593309612

A balanced choice for knee osteoarthritis pain relief

GELSYN-3 Hyaluronic Acid Therapy

GELSYN-3 is a three-injection hyaluronic acid therapy manufactured with the latest dual filtration and purification technology, which virtually eliminates contaminants and impurities—including proteins and endotoxins—and is delivered with a consistent balance of molecular weight and viscosity.^9,40

GELSYN-3 is committed to advancing the benefits of hyaluronic acid therapy with:

Fully automated production methods that prevent contamination and human error³⁶
Low level of impurities, including proteins and bacterial endotoxins⁴⁰
Bacterial fermentation of Streptococcus groups that’s safe and not genetically modified (non-GMO)^36,40

Manufacturing Videos

Gelsyn videos7

Step 1 – Preparation of Solution

Gelsyn videos8

Step 2 – Filling Phase

Gelsyn videos9

Step 3 – Visual Inspection Department

Gelsyn videos10

Step 4 – Packaging

Gelsyn videos11

Step 5 – Quality Control

Review Science-Driven Results

DUROLANE, GELSYN-3 and SUPARTZ FX are indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g., acetaminophen. Risks include general knee pain and pain at the injection site.

View Use and Important Safety Information at: DUROLANE.com, GELSYN3.com, and SUPARTZFX.COM

Summary of Indications for Use:
DUROLANE is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacological therapy or simple analgesics, e.g. acetaminophen.

Do not inject DUROLANE in patients with knee joint infections, skin diseases, or other infections in the area of the injection site. Do not administer to patients with known hypersensitivity or allergy to sodium hyaluronate preparations. Risks can include transient pain or swelling at the injection site.

DUROLANE has not been tested in pregnant or lactating women, or children.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

Summary of Indications for Use:
GELSYN-3 is indicated for the treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics (e.g., acetaminophen). Do not administer to patients with known hypersensitivity (allergy) to sodium hyaluronate preparations. Do not inject GELSYN-3 into the knees of patients having knee joint infections or skin diseases or infections in the area of the injection site.

GELSYN-3 is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.

Summary of Indications for Use:
SUPARTZ FX is indicated for treatment of pain in osteoarthritis (OA) of the knee in patients who have failed to respond adequately to conservative non-pharmacologic therapy and simple analgesics, e.g., acetaminophen. You should not use SUPARTZ FX if you have infections or skin diseases at the injection site or allergies to poultry products. SUPARTZ FX is not approved for pregnant or nursing women, or children. Risks can include general knee pain, warmth and redness or pain at the injection site.

Full prescribing information can be found in product labeling, or by contacting Bioventus Customer Service at 800-836-4080.